- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Podcast: Implementing a Hybrid PET/MR System
Pamela Woodard, MD, of the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis, discusses the challenges and benefits of being an early adopter of this technology.
[[{"type":"media","view_mode":"media_crop","fid":"8216","attributes":{"alt":"Siemens Biograph mMR PET/MR","class":"media-image media-image-left","id":"media_crop_4872934844629","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"217","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 5px; float: left;","title":" ","typeof":"foaf:Image"}}]]Pioneering a new imaging technology is far more complicated than plugging it in and scanning patients. At the Mallinckrodt Institute of Radiology, Washington University School of Medicine in St. Louis, implementing the Siemens Biograph mMR hybrid PET/MR system requires the radiologists to develop the protocols.
"It's a very new piece of equipment," said Pamela Woodard, MD, of the Center for Clinical Imaging Research (CCIR), Mallinckrodt Institute of Radiology, Washington University School of Medicine. "It's not like a CT scanner that everyone has been using for 35 years and you just start scanning."
Washington University School of Medicine is only the third site in the U.S. to have this equipment, with two other sites set to come online soon. Siemens received FDA 510(k) clearance in June 2011 for the Biograph mMR, the first system to allow for simultaneous whole-body scanning by MR and PET.
[[{"type":"media","view_mode":"media_crop","fid":"11970","attributes":{"alt":"Pamela Woodward","class":"media-image","id":"media_crop_590670178982","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"216","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]And despite the start-up challenges, the lower dose and the simultaneous scans provide some major benefits for patients, according to Woodard. In this podcast, Woodard explains how this technology is being used, why her institution became an early adopter, and what they've learned so far.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
Diffusion-Weighted MRI and Neoadjuvant Chemotherapy for Rectal Cancer: What New Research Reveals
September 3rd 2024In a comparison of imaging assessments to gauge the effectiveness of neoadjuvant chemotherapy for rectal adenocarcinoma, researchers found the combination of diffusion-weighted imaging and MR tumor regression grading had a 90 percent area under the curve (AUC) and a negative predictive value (NPV) of 93 percent.
FDA Expands Clearance of MRI-Guided AI Platform for Deep Brain Stimulation and Lesioning Techniques
September 3rd 2024Utilizing a new machine learning model, the OptimMRI software may improve radiosurgery applications and lesioning techniques such as MRI-guided focused ultrasound through enhanced targeting of the inferolateral part of the ventral intermediate nucleus (VIM).
